Find Federal Grants
Bioequivalence of Topical Products: Bioequivalence Considerations for Ungual, Scalp, Vaginal, Anal or Rectal Dosage Forms (U01 Clinical Trial Not Allowed)
Food and Drug Administration · RFA-FD-19-008
Patient Reported Outcomes Tool Development for Use in Non-Cystic Fibrosis Bronchiectasis Clinical Trials (U01- Clinical Trial Required) Activity Code
Food and Drug Administration · RFA-FD-19-014
Validating Human Stem Cell Cardiomyocyte Technology for Better Predictive Assessment of Drug-Induced Cardiac Toxicity (U01 Clinical Trial Not Allowed)
Food and Drug Administration · RFA-FD-19-002
Request for Information (RFI): FDA Standard Core Clinical Outcome Assessments and Endpoints
Food and Drug Administration · RFI-NOT-FD-18-014
Food and Drug Administration · PAR-18-827
Bureau of Reclamation · BOR-LC-18-N006
Development of a virtual bioequivalence trial simulation platform that integrates population pharmacokinetic modeling algorithms into physiologically-based pharmacokinetic models (U01)
Food and Drug Administration · RFA-FD-18-018
Cooperative Agreement to Support Regulatory Research Related to the 2018 Prescription Drug User Fee Act and the 21st Century Cures Act (U19)
Food and Drug Administration · RFA-FD-18-025
BJA FY 18 The Intellectual Property Enforcement Program: Protecting Public Health, Safety, and the Economy from Counterfeit Goods and Product Piracy
Bureau of Justice Assistance · BJA-2018-13611
BJA FY 18 Economic, High-Technology, White Collar, and Internet Crime Prevention National Training and Technical Assistance Program
Bureau of Justice Assistance · BJA-2018-13565
Strengthen Regulatory Systems to Ensure the Safety and Quality of Food and Medical Products (U01)
Food and Drug Administration · RFA-FD-18-022
Enhancing Innovations in Emerging Technologies for Advanced Manufacturing of Complex Biologic Products (R01)
Food and Drug Administration · RFA-FD-18-023
Food and Drug Administration · RFA-FD-18-009
Exploration of HL7 FHIR Standards for Clinical Research and Post-market Surveillance (U24)
Food and Drug Administration · RFA-FD-18-016
Food and Drug Administration · RFA-FD-18-021
Renewal Applications: Centers of Excellence in Regulatory Science and Innovation (U01)
Food and Drug Administration · RFA-FD-18-011
Bioequivalence of Topical Products: Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Non-Invasive Techniques (U01)
Food and Drug Administration · RFA-FD-18-012
Computational fluid dynamics (CFD) and discrete element modeling (DEM) approach for predictions of dry powder inhaler (DPI) drug delivery (U01)
Food and Drug Administration · RFA-FD-18-014
Three-Dimensional Approach for Modeling Nasal Mucociliary Clearance via Computational Fluid Dynamics (CFD) (U01)
Food and Drug Administration · RFA-FD-18-020
Formulation drug product quality attributes in dermal physiologically-based pharmacokinetic models for topical dermatological drug products and transdermal delivery systems (U01)
Food and Drug Administration · RFA-FD-18-019